Cotización Dogwood Therapeutics - DWTX

Herramientas de nivel profesional para inversores individuales.

Premium

Último Precio

2.82

Postura de Compra

2.48

Postura de Venta

2.95

Volume Operado de la Acción

0.00 Rango del Día 0.00

1.62 Rango de 52 semanas 5.29

Precio Anterior

2.82

Precio de Apertura

Hora

2.73

Última hora de negociación

05:43:59

Volumen promedio (3 m)

88,922

Volumen financiero

Precio Promedio Ponderado

Dogwood Therapeutics, Inc. Announces Low Dose IMC-2 Treatment Reduces Long-COVID Related Fatigue and Sleep Disturbance in an Investigator-Initiated Study

- IMC-2 treatment, dosed as valacyclovir 750 mg + celecoxib 200 mg twice daily, demonstrated clinically meaningful reduction in Long-COVID related fatigue and sleep disturbance as compared to...

Dogwood Therapeutics Announces Third Quarter 2024 Financial Results

- Dogwood Therapeutics, Inc. (Nasdaq: “DWTX”) formed in October by combination of Virios Therapeutics, Inc. and Pharmagesic (Holdings) Inc., 100% parent company of Wex Pharmaceuticals, Inc. (the...

Dogwood Therapeutics to Report Third Quarter 2024 Financial Results and Provide Corporate Update on Thursday, November 7, 2024

ATLANTA, Oct. 31, 2024 (GLOBE NEWSWIRE) -- Dogwood Therapeutics, Inc. (Nasdaq: DWTX) (the “Company”), formerly Virios Therapeutics, Inc., a clinical‐stage biopharmaceutical company, announced...

Dogwood Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement

ATLANTA, Oct. 30, 2024 (GLOBE NEWSWIRE) -- Dogwood Therapeutics, Inc. (Nasdaq: DWTX) (the “Company”), formerly Virios Therapeutics, Inc., a clinical‐stage biopharmaceutical company, announced...

Virios Therapeutics, Inc. and Wex Pharmaceuticals, Inc. Announce Business Combination to Form Dogwood Therapeutics, Inc. (Nasdaq: “DWTX”)

Strategic financing by an affiliate of CK Life Sciences Int’l., (Holdings) Inc., results in working capital of approximately $23 million to fund operations and advance Phase 2b Halneuron®...

Período †	Variación(Ptos)	Variación %	Apertura	Precio Máximo	Precio Mínimo	Avg. Vol. diario	Precio Promedio Ponderado
1	0.43	17.9916317992	2.39	2.9999	2.33	43598	2.7570561	CS
4	0.46	19.4915254237	2.36	2.9999	2.28	24669	2.5584447	CS
12	-0.73	-20.5633802817	3.55	5.29	1.62	88922	3.50165133	CS
26	-0.73	-20.5633802817	3.55	5.29	1.62	88922	3.50165133	CS
52	-0.73	-20.5633802817	3.55	5.29	1.62	88922	3.50165133	CS
156	-0.73	-20.5633802817	3.55	5.29	1.62	88922	3.50165133	CS
260	-0.73	-20.5633802817	3.55	5.29	1.62	88922	3.50165133	CS

DWTX - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Dogwood Therapeutics?

El precio actual de las acciones de Dogwood Therapeutics es US$ 2.82

¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Dogwood Therapeutics?

Dogwood Therapeutics ha negociado en un rango de US$ 1.62 a US$ 5.29 durante el último año

Volumen
% Mayores Alzas
% Mayores Bajas

Símbolo	Precio	Vol.
NXUNXU Inc	US$ 1.00 (310.85%)	116.05M
WATTEnergous Corporation	US$ 1.30 (216.15%)	64.03M
INTZIntrusion Inc	US$ 4.58 (112.04%)	25.26M
OCTOEightco Holdings Inc	US$ 2.95 (84.38%)	20.3M
NLSPNLS Pharmaceutics Ltd	US$ 3.02 (65.93%)	15.27M
TRAWTraws Pharma Inc	US$ 7.80 (-41.88%)	478.21k
LITMSnow Lake Resources Ltd	US$ 0.9923 (-37.98%)	11.08M
FMSTForemost Clean Energy Ltd	US$ 1.00 (-35.48%)	12
BITSGlobal X Blockchain and Bitcoin Stratagy ETF	US$ 67.01 (-24.25%)	1.23k
RPAYRepay Holdings Corporation	US$ 6.01 (-22.35%)	1
NXUNXU Inc	US$ 1.00 (310.85%)	116.05M
WATTEnergous Corporation	US$ 1.30 (216.15%)	64.03M
VINCVincerx Inc	US$ 0.308 (58.76%)	26.91M
INTZIntrusion Inc	US$ 4.58 (112.04%)	25.26M
SMXSMX Security Matters Public Company	US$ 0.467 (32.07%)	24.99M